AN Venture Partners
Venture capitalActively deployingTokyo · Pre-Seed–Growth · 21 people tracked
Also known as ANV MANAGEMENT, LLC
Investment thesis
AN Venture Partners positions itself at the intersection of science, capital, and innovation, aiming to advance scientific progress on a global scale. The firm invests in startups it believes will shape the future, drawing on a highly experienced core team and a worldwide network of experts. Its emphasis on scientific and deep-technology ventures suggests a focus on research-driven companies, though the page does not detail specific stages, check sizes, or sectors.
Source: firm website, verified Aug 3, 2026.
Team · 21 people
from the firm's website
What they invest in
from 2 of 8 portfolio companiesBiotech ×2Medical Devices ×1
HQs:United States×2
Investments · 8 tracked
founders shown can be your intro pathBiotechPalo Alto, US
Kenneth Horne(Executive Officer, Director)Dylan Morris(Director)Amy Wang(Executive Officer, Director)Cristina Ghenoiu(Director)
BoardTaro Inaba(Director)
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)
US-based neuroscience company and AN Venture Partners portfolio investment.
Portfolio news
latest coverage across their companiesCity Therapeutics · finsmes.com · Jun 9, 2026
Frequently asked questions
- What stage does AN Venture Partners invest at?
- AN Venture Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does AN Venture Partners focus on?
- AN Venture Partners focuses on Biotech, Deep Tech.
- Where is AN Venture Partners located?
- AN Venture Partners is headquartered in Tokyo, JP.
- Does AN Venture Partners lead rounds?
- AN Venture Partners typically participates in rounds rather than leading them.
Images
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Innovestor is a Nordic investment group operating across venture capital, life science, real estate, energy storage, and corporate venturing platforms, and is among the most active early-stage investors in the region.
Inveready is a Spanish alternative investment firm founded in 2008, offering investment solutions and wealth management services across the small and mid-market segment in Spain.
Octopus Ventures is a founder-focused European venture capital firm that backs mission-driven startups across seven core sectors, investing from idea stage through growth with a focus on pre-seed to Series A.